EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Avacopan’s potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis

Tomoki Taniguchi iD, Ryosuke Hiwa iD, Mikihito Shoji, Eriho Yamaguchi, Mirei Shirakashi iD, Hideo Onizawa, Hideaki Tsuji iD, Koji Kitagori, Ran Nakashima iD, Shuji Akizuki, Akira Onishi, Hajime Yoshifuji iD und 2 weitere

Modern Rheumatology Case Reports · 08.07.2024 · 8 (2) · 314-317

DOI: 10.1093/mrcr/rxae016 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 29.03.2024. Verfasst von Tomoki Taniguchi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Peroxidase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avacopan, an orally administered C5a receptor antagonist, is effective in microscopic polyangiitis via the inhibition of neutrophil priming induced by C5a. However, the exact effect of avacopan on the production of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) is yet to be clearly established. This report presents a microscopic polyangiitis patient without major organ damage where high levels of MPO-ANCA persisted with high-dose steroid therapy and azathioprine, but the addition of avacopan led to a reduction in MPO-ANCA titres. The present case implies that avacopan-mediated inhibition of C5a may lead to a reduction in MPO-ANCA levels, thereby potentially ameliorating the pathophysiology of ANCA-associated vasculitis. Nevertheless, the impact of avacopan on MPO-ANCA production cannot be asserted solely based on this report; therefore, further examination is necessary through subgroup analysis using data from larger-scale studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisPeroxidaseHumansAgedPositron Emission Tomography Computed TomographyNeutrophilsCytoplasmImmunoassay

Stichwörter der Autor:innen

Microscopic polyangiitis (MPA)avacopanmyeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA)

Substanzen

MPO protein, humanPeroxidase

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

ORCID-Profile: Tomoki Taniguchi, Ryosuke Hiwa, Mirei Shirakashi, Hideaki Tsuji, Ran Nakashima, Hajime Yoshifuji

Zitieren

APA

Taniguchi, T., Hiwa, R., Shoji, M., Yamaguchi, E., Shirakashi, M., Onizawa, H., Tsuji, H., Kitagori, K., Nakashima, R., Akizuki, S., Onishi, A., Yoshifuji, H., Tanaka, M., & Morinobu, A. (2024). Avacopan’s potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis. Modern Rheumatology Case Reports, 8(2), 314-317. https://doi.org/10.1093/mrcr/rxae016

Vancouver

Taniguchi T, Hiwa R, Shoji M, Yamaguchi E, Shirakashi M, Onizawa H, et al. Avacopan’s potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis. Modern Rheumatology Case Reports. 2024;8(2):314-317. doi:10.1093/mrcr/rxae016

BibTeX
@article{Taniguchi2024,
  author = {Taniguchi, Tomoki and Hiwa, Ryosuke and Shoji, Mikihito and Yamaguchi, Eriho and Shirakashi, Mirei and Onizawa, Hideo and Tsuji, Hideaki and Kitagori, Koji and Nakashima, Ran and Akizuki, Shuji and Onishi, Akira and Yoshifuji, Hajime and Tanaka, Masao and Morinobu, Akio},
  title = {Avacopan’s potential to decrease MPO-ANCA titres concurrent with ameliorated activity in ANCA-associated vasculitis},
  journal = {Modern Rheumatology Case Reports},
  year = {2024},
  volume = {8},
  number = {2},
  pages = {314--317},
  doi = {10.1093/mrcr/rxae016}
}
Kostenlos starten →